Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Anastrozole
Drug ID BADD_D00142
Description Anastrozole is a non-steroidal aromatase inhibitor (AI), similar to [letrozole], used to decrease circulating estrogen levels in the treatment of postmenopausal women with estrogen-responsive breast cancer.[L8863] Anastrozole is also related to [exemestane], a steroidal AI, but its non-steroidal nature provides stark advantages including a lack of steroid-associated adverse effects such as weight gain and acne.[A186865] Aromatase inhibitors, including anastrozole, have become endocrine drugs of choice in the treatment of postmenopausal breast cancer due to a more favourable efficacy and adverse effect profile as compared to earlier estrogen receptor modulators such as [tamoxifen].[A186877,A186955] Anastrozole was first approved for use in the United States in 1995.[L8863]
Indications and Usage For adjuvant treatment of hormone receptor positive breast cancer , as well as hormonal treatment of advanced breast cancer in post-menopausal women. Has also been used to treat pubertal gynecomastia and McCune-Albright syndrome; however, manufacturer states that efficacy for these indications have not been established.
Marketing Status Prescription; Discontinued
ATC Code L02BG03
DrugBank ID DB01217
KEGG ID D00960
MeSH ID D000077384
PubChem ID 2187
TTD Drug ID D0W0BF
NDC Product Code 63850-6527; 0395-8157; 68554-0026; 0310-0201; 71335-1879; 65129-1119; 16729-035; 68071-1682; 71052-248; 72789-008; 65096-0117; 51991-620; 59651-236; 65072-0702; 63629-5269; 16571-421; 63850-0010; 82393-201; 62135-490; 63187-080; 62559-670; 50090-2453; 58623-0041; 55111-814; 68382-209; 51927-4435; 68001-155; 50090-5002; 65841-743; 76420-004; 50268-075; 0093-7536; 61200-104; 42291-085; 46014-1160; 70518-2484; 73377-120; 69988-0013; 50090-5812; 62756-428; 62157-077; 70934-488; 70518-2420; 60429-286; 68071-5203; 60687-112; 51552-1568; 46014-1009; 38779-2555; 0904-6195; 43063-383; 60440-2921; 53104-7627; 62175-710
Synonyms Anastrozole | 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile) | Anastrazole | Arimidex | ICI D1033 | ZD-1033 | ZD 1033 | Zeneca ZD 1033 | ZD1033
Chemical Information
Molecular Formula C17H19N5
CAS Registry Number 120511-73-1
SMILES CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
Chemical Structure
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Cardiomyopathy02.04.01.0010.002263%Not Available
Cardiovascular disorder02.01.01.001; 24.03.02.009--Not Available
Carpal tunnel syndrome17.09.02.0010.000492%Not Available
Cataract06.06.01.0010.001508%
Cellulitis11.02.01.001; 23.09.01.0010.001886%Not Available
Cerebral haemorrhage17.08.01.003; 24.07.04.0010.000393%Not Available
Cerebral infarction17.08.01.004; 24.04.06.0020.002640%Not Available
Cerebral ischaemia17.08.01.005; 24.04.06.0030.001131%
Cerebral thrombosis17.08.01.006; 24.01.04.0030.000754%Not Available
Cerebrovascular accident17.08.01.007; 24.03.05.001--
Cervix carcinoma16.12.01.001; 21.06.02.0010.001508%Not Available
Chest pain02.02.02.011; 08.01.08.002; 22.02.08.003--Not Available
Chronic hepatitis09.01.07.021; 11.07.01.0090.002263%Not Available
Colitis07.08.01.0010.000754%
Colon cancer07.21.01.001; 16.13.01.0010.000492%Not Available
Confusional state17.02.03.005; 19.13.01.001--
Constipation07.02.02.001--
Coronary artery disease02.02.01.001; 24.04.04.006--Not Available
Cough22.02.03.0010.004148%
Cutaneous vasculitis10.02.02.003; 23.06.02.001; 24.05.02.0040.001508%Not Available
Cyst08.03.05.001; 16.02.02.002--Not Available
Cystitis11.01.14.001; 20.03.02.0020.000754%
Deafness04.02.01.0010.000754%Not Available
Death08.04.01.001--
Dehydration14.05.05.001--
Dementia Alzheimer's type17.03.06.001; 19.20.03.0010.001886%Not Available
Depression19.15.01.0010.007542%
Dermatitis23.03.04.0020.001131%Not Available
Dermatitis bullous23.03.01.002--
Diabetes mellitus05.06.01.001; 14.06.01.001--Not Available
The 3th Page    First    Pre   3 4 5 6 7    Next   Last    Total 16 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene